Suppr超能文献

高价吡唑盐桥联铂配合物:一项实验与理论联合研究

High-Valent Pyrazolate-Bridged Platinum Complexes: A Joint Experimental and Theoretical Study.

作者信息

Arnal Lorenzo, Escudero Daniel, Fuertes Sara, Martin Antonio, Sicilia Violeta

机构信息

Departamento de Química Inorgánica, Facultad de Ciencias, Instituto de Síntesis Química y Catálisis Homogénea (ISQCH), CSIC - Universidad de Zaragoza, Pedro Cerbuna 12, 50009 Zaragoza, Spain.

Department of Chemistry, KU Leuven, Celestijnenlaan 200f - box 2404, 3001 Leuven, Belgium.

出版信息

Inorg Chem. 2022 Aug 15;61(32):12559-12569. doi: 10.1021/acs.inorgchem.2c01441. Epub 2022 Aug 3.

Abstract

Complexes [{Pt(C^C*)(μ-pz)}] (HC^C* = 1-(4-(ethoxycarbonyl)phenyl)-3-methyl-1-imidazol-2-ylidene , HC^C* = 1-phenyl-3-methyl-1-imidazol-2-ylidene ) react with methyl iodide (MeI) at room temperature in the dark to give compounds [{Pt(C^C*)Me(μ-pz)}(μ-I)]I (C^C* , C^C* ). The reaction of with benzyl bromide (BnBr) in the same conditions afforded [Br(C^C*)Pt(μ-pz)Pt(C^C*)Bn] (), which by heating in BnBr(l) became [{Pt(C^C*)Bn(μ-pz)}(μ-Br)]Br (). Experimental investigations and density functional theory (DFT) calculations on the mechanisms of these reactions from revealed that they follow a S2 pathway in the two steps of the double oxidative addition (OA). Based on the DFT investigations, species such as [(C^C*)Pt(μ-pz)Pt(C^C*)R]X (RX = MeI , BnBr ) and [(C^C*)Pt(μ-pz)Pt(C^C*)(R)X] (RX = MeI , BnBr ) were proposed as intermediates for the first and the second OA reactions, respectively. In order to put the mechanisms on firmer grounds, was prepared as [(C^C*)Pt(μ-pz)Pt(C^C*)Me]BF () and used to get I(C^C*)Pt(μ-pz)Pt(C^C*)Me, (C^C*)Pt(μ-pz)Pt(C^C*)(Me)I, and [{Pt(C^C*)Me(μ-pz)}(μ-I)]BF (). The single-crystal X-ray structures of , , , and along with the mono- and bi-dimensional H and Pt{H} NMR spectra of all the named species allowed us to compare structural and spectroscopic data for high-valent complexes with the same core [{Pt(C^C*)(μ-pz)}] but different oxidation states.

摘要

配合物[{Pt(C^C*)(μ - pz)}](HC^C* = 1 - (4 - (乙氧羰基)苯基)-3 - 甲基 - 1 - 咪唑 - 2 - 亚基,HC^C* = 1 - 苯基 - 3 - 甲基 - 1 - 咪唑 - 2 - 亚基)在室温黑暗条件下与碘甲烷(MeI)反应,生成化合物[{Pt(C^C*)Me(μ - pz)}(μ - I)]I(C^C*,C^C*)。在相同条件下, 与苄基溴(BnBr)反应得到[Br(C^C*)Pt(μ - pz)Pt(C^C*)Bn](),该化合物在BnBr(液体)中加热后变为[{Pt(C^C*)Bn(μ - pz)}(μ - Br)]Br()。对这些反应机理的实验研究和密度泛函理论(DFT)计算表明,它们在双氧化加成(OA)的两步中遵循S2途径。基于DFT研究,分别提出[(C^C*)Pt(μ - pz)Pt(C^C*)R]X(RX = MeI,BnBr)和[(C^C*)Pt(μ - pz)Pt(C^C*)(R)X](RX = MeI,BnBr)等物种作为第一次和第二次OA反应的中间体。为了使机理更可靠, 将[(C^C*)Pt(μ - pz)Pt(C^C*)Me]BF()制备出来,并用于得到[I(C^C*)Pt(μ - pz)Pt(C^C*)Me]()、[(C^C*)Pt(μ - pz)Pt(C^C*)(Me)I]()和[{Pt(C^C*)Me(μ - pz)}(μ - I)]BF()。 、 、 和 的单晶X射线结构以及所有上述物种的一维和二维H和Pt{H} NMR光谱,使我们能够比较具有相同核心[{Pt(C^C*)(μ - pz)}]但氧化态不同的高价配合物的结构和光谱数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e380/9387385/69a981045f5c/ic2c01441_0002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验